Fierce Biotech

  1. Ventyx nabs a $152M upsized IPO to challenge BMS' Zeposia—and a backer with intimate knowledge of its rival badams Thu, 10/21/2021 - 09:00
  2. VCs back Leucid to trial CAR-T twist in ovarian cancer patients ntaylor Thu, 10/21/2021 - 08:09
  3. Menarini, chased by 3 Big Pharmas, records win in breast cancer phase 3, plots path to FDA ntaylor Thu, 10/21/2021 - 06:12
  4. FDA slaps clinical hold on AstraZeneca cancer drug amid heart safety scare in combo test badams Wed, 10/20/2021 - 13:59
  5. Chase, after selling last biotech to Allergan, gets cash to start pivotal trials in depression, Parkinson's  ntaylor Wed, 10/20/2021 - 08:43